Patients’ profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France

医学 生活质量(医疗保健) 疾病 儿科 人口学 内科学 护理部 社会学
作者
Brigitte Dréno,Jean-Elie Malkin,Philippe Saïag,S. Batuji‐Garin
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:26 (11): 1458-1460 被引量:16
标识
DOI:10.1111/j.1468-3083.2011.04348.x
摘要

Editor Herpes labialis (HL) is a very frequent disease that affects millions of people. In France, the HERPIMAX study reported a lifetime prevalence of 38.3% and the INSTANT study showed an annual prevalence of 14.8%.1 Although benign, HL is disabling and may have a significant impact on quality of life (QOL) as suggested by Lorette et al.1 The purpose of HERPESCOPE was to describe patients’ profiles, to understand the burden of disease and to assess the impact on QOL, in France and in the US. The HERPESCOPE, conducted by Nielsen, took place in November 2010. The sample was constituted according to the quotas method. All respondents, aged ≥18 years, were screened on having, themselves and/or their child, at least one episode of HL in the past 12 months. Patients having at least one episode in the last 4 weeks completed the QOL – SF-36 questionnaire.2–4 Comparisons were performed between patients with <4 episodes per year (CHL) and those with ≥4 episodes per year (FHL). A group of very frequent HL (VFHL ≥6) was individualized. 1002 and 1005 patients participated in the study and 437 and 476 completed the SF36 questionnaire, in the US and France, respectively. The profile of the patients was very similar to that established in INSTANT study,1 which confirms that there was no bias related to the sample profile (female patients: 59% and 58%, respectively, median class of ages 30–39 years). The mean annual numbers of episodes were high, respectively, 3.6 and 3.4. In both countries, FHL affects 35% of patients suffering from the disease (median of five episodes), and VFHL, 15% of them (median of eight episodes). In both countries, more than 75% of patients declared reacting during the prodromal phase, before redness appears (Table 1). In the US, FHL patients had earlier reactions than CHL patients (NS in France). The management of FHL and CHL patients was different. In both countries, for FHL patients the higher the number of episodes was, the higher the resort to physicians was (more marked in the US). In the US, FHL patients visited a doctor, or used an old prescription, more frequently than CHL patients (57% treated their herpes by themselves). In France, CHL patients asked a pharmacist’s advice (28%). HL episodes lead to frequent sick leaves, with longer durations in FHL groups. Among patients who followed a medical advice to treat their herpes, in US 45% stopped working due to their HL episode (33% with a sick leave, mostly among the FHL group; median duration: 5 and 3 days in the FHL and CHL groups, respectively) and in France 21% (14% with a sick leave; median duration: 5 and 3 days in the FHL and CHL groups, respectively). Quality of life, impaired in more than 80% of cases, is significantly more affected in FHL patients (Table 2). Approximately two-thirds of respondents reported an impact of their physical and/or emotional condition, more pronounced in FHL patients. A majority of patients were disturbed in their social life. Physical pain, reported by more than 90% of patients, was significantly more severe in the FHL groups. Physical pain had a negative effect on work and chores, the impact being significantly higher in FHL patients. Health condition limited patients in physical activity. The majority of patients were regularly tired or exhausted and the perception of their health was impaired in FHL patients. These results are consistent with those obtained in the Lorette study that showed significantly lower QOL scores in subjects with at least six episodes per year. These data reflect the burden of disease associated with HL.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ylky发布了新的文献求助10
3秒前
科研通AI2S应助浮浮世世采纳,获得10
3秒前
传奇3应助华中科技大学采纳,获得10
3秒前
情怀应助WN采纳,获得10
4秒前
4秒前
7秒前
朴实山兰完成签到,获得积分10
9秒前
11秒前
SciGPT应助ylky采纳,获得10
11秒前
小爪冰凉发布了新的文献求助10
11秒前
12秒前
量子星尘发布了新的文献求助10
12秒前
JamesPei应助科研小牛采纳,获得150
13秒前
Ava应助科研小牛采纳,获得10
13秒前
13秒前
忧郁盼夏发布了新的文献求助10
16秒前
marina关注了科研通微信公众号
16秒前
沐紫心完成签到 ,获得积分10
17秒前
科研通AI5应助suger采纳,获得10
17秒前
19秒前
八九发布了新的文献求助10
19秒前
22秒前
22秒前
一个好听的名字完成签到,获得积分10
23秒前
wbh发布了新的文献求助20
23秒前
23秒前
24秒前
Eddoes完成签到,获得积分10
24秒前
WN发布了新的文献求助10
25秒前
诚心的凌旋完成签到,获得积分10
25秒前
leanne发布了新的文献求助10
27秒前
机智思真完成签到,获得积分10
27秒前
28秒前
科研小牛完成签到,获得积分10
28秒前
归尘发布了新的文献求助10
28秒前
万物安生发布了新的文献求助10
28秒前
阿钉发布了新的文献求助10
28秒前
29秒前
张钦奎发布了新的文献求助10
29秒前
29秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173